There is an increasing interest in the discovery of new inflammatory bowel disease (IBD) biomarkers able to predict the future patterns of disease and to help in diagnosis, treatment, and prognosis. A biomarker is a substance that can be measured biologically and is associated with an increased risk
QSAR methods for the discovery of new inflammatory bowel disease drugs
✍ Scribed by García-Domenech, Ramón; Gálvez-Llompart, María; Zanni, Riccardo; Recio, María C; Gálvez, Jorge
- Book ID
- 120477553
- Publisher
- Informa plc
- Year
- 2013
- Tongue
- English
- Weight
- 654 KB
- Volume
- 8
- Category
- Article
- ISSN
- 1746-0441
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Background: Although tumor necrosis factor (tnf) antagonists are effective for the treatment of crohn's disease and ulcerative colitis, lack and loss of clinical response is a clinical challenge. accordingly, the use of therapeutic drug monitoring has been proposed as a means to optimize treatme
This article shall give an overview on drug delivery systems for new therapeutic strategies in the treatment of inflammatory bowel disease. The various features of the different approaches allowing locally restricted drug delivery to the inflamed colon are discussed including the main physiological